All In Biotech

Drug Trial Radar · NCT04797650

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Last checked: Nov 19, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 517 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

517

Actual

Start

Jun 10, 2021

Primary completion

Jun 8, 2022

Study completion Jun 29, 2022

Sponsor

Lead sponsor
Concert PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss.

Conditions

  • Alopecia Areata

Interventions

  • CTP-543 matching placeboDrug

    Administered as tablets.

  • CTP-543Drug

    Administered as tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) Score ≤20 at Week 24Time frame: Week 24

Locations

63 sites in 7 countries. Site status is shown where the registry gives one.

  • Alliance Dermatology & Mohs Center

    Phoenix, Arizona

  • Johnson Dermatology

    Fort Smith, Arkansas

  • Dermatology Research Associates

    Los Angeles, California

  • University of Miami Hospital

    Miami, Florida

  • Floridian Research Institute LLC

    Miami, Florida

  • MetroBoston Clinical Partners, LLC

    Brighton, Massachusetts

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan

  • Hamzavi Dermatology

    Fort Gratiot, Michigan

  • Galen Research

    Chesterfield, Missouri

  • Vivida Dermatology

    Las Vegas, Nevada

  • The Dermatology Group P.C.

    Verona, New Jersey

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Columbia University Medical Center - Department of Dermatology

    New York, New York

  • University of Rochester

    Rochester, New York

  • Dermatologists of Southwest Ohio

    Mason, Ohio

  • Oregon Medical Research

    Portland, Oregon

  • Velocity Clinical Research - Providence

    Warwick, Rhode Island

  • The Skin Wellness Center

    Knoxville, Tennessee

  • North Texas Center for Clinical Research

    Frisco, Texas

  • Elixir Research Group

    Houston, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Velocity Clinical Research/Gateway

    Salt Lake City, Utah

  • Velocity Clinical Research/Swinyer-Woseth Dermatology

    Salt Lake City, Utah

  • Jordan Valley Dermatology Center

    South Jordan, Utah

  • The Rector and Visitors of the University of Virginia

    Charlottesville, Virginia

  • Centre de Recherche Saint-Louis

    Québec, Canada

  • Centre de Recherche Dermatologique du Quebec Metropolitan

    Québec, Canada

  • Care Clinic Ltd.

    Red Deer, Alberta, Canada

  • Medical Arts Health Research Group

    Kelowna, British Columbia, Canada

  • Kingsway Clinical Research

    Etobicoke, Ontario, Canada

  • North Bay Dermatology Centre

    North Bay, Ontario, Canada

  • The Centre for Dermatology

    Richmond Hill, Ontario, Canada

  • Centre Hospitalier Universitaire de Nice - Hôpital Archet 2

    Nice, Alpes-maritimes, France

  • Chru de Brest - Hôpital Morvan

    Brest, Finestère, France

  • Clinical Research Center for Hair and Skin Science, Dept of Dermatology, Charité Universitätsmedizin Berlin

    Berlin, Germany

  • Universitätsklinikum Erlangen Hautklinik

    Erlangen, Germany

  • Universitaetsklinikum Tübingen

    Tübingen, Baden-Wurttemberg, Germany

  • Klinikum Rechts Der Isar, Technische Universität München

    Munich, Bavaria, Germany

  • Universitätsklinikum Frankfurt Klinik Für Dermatologie, Venerologie Und Allergologie

    Frankfurt am Main, Hesse, Germany

  • Fachklinik Bad Bentheim - Dermatologische Studienambulanz

    Bad Bentheim, Lower Saxony, Germany

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.